
This is an exciting opportunity to lead market access strategy for Omnipod across Canada, working directly with provincial and private payers to expand coverage and improve access for people living with diabetes. In this highly visible role, you'll shape reimbursement strategy, lead provincial submissions from concept through approval, influence key coverage decisions, and partner closely with Sales, Marketing, and Reimbursement teams. It's an ideal opportunity for someone who enjoys combining payer relations, health policy, reimbursement, and strategic business planning while making a meaningful impact on both patient outcomes and commercial growth.
The Manager, Market Access is responsible for developing strategically targeted payer engagement, relationship and account management at the country and provincial level for improved access and procurement of the Omnipod products across the country. This includes implementing access agreements and proposing opportunities to streamline the burden of administration where possible.
Efforts of this individual should focus on ensuring health care providers and people living with diabetes have unimpeded access to our products and services by educating payors and influencing their medical policy decisions, their perceptions of the value Insulet provides them and their patients, and our competitive position relative to alternatives. This role is expected to earn the support of his/her customers (internal and external) as a trusted business advisor. Success is reflected by the key payor stakeholders accepting and implementing versions of the recommendations to the payor. The successful candidate will have a deep understanding of the necessary Province related business issues, have broad knowledge of the evolving healthcare landscape, will develop detailed strategic plans which align with the long and short-term goals of the organization.
*Applicants must be located within commuting distance of our Oakville, ON office location to be considered.
NOTE: This position is eligible for hybrid working arrangements and requires on-site work from an Insulet office. #LI-Hybrid
Pay Range: The expected salary for this position is $147,000.00 - $189,000.00 CAD annually. Vacancy Status: This posting is for an existing vacancy.

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to simplifying life for people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the tubeless disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet’s flagship innovation, the Omnipod 5 Automated Insulin Delivery System, integrates with a continuous glucose monitor to manage blood sugar with no multiple daily injections, zero fingersticks, and can be controlled by a compatible personal smartphone in the U.S. or by the Omnipod 5 Controller. Omnipod products are offered in 25 countries around the globe.
HIRING SCAM ALERT
Recently, individuals impersonating Insulet Human Resources members have offered fraudulent interviews and job offers to unsuspecting candidates. To help protect you from these scam artists, please be aware that:
• Insulet will never interview a candidate over RingCentral, similar messaging apps or social media (i.e. Google Hangouts, WhatsApp, Facebook Messenger, etc.), or via text message.
• Insulet will never send a company check or ask an applicant to pay a fee or purchase at home work/training materials in connection with an application for employment.
• Insulet will never provide excess money to an applicant and ask the applicant to write a check for repayment.
If you have any doubt about a job offer or any other communication purporting to come from Insulet, please reach out to us directly at 978-600-7000.
If you receive any type of communication on behalf of Insulet that seems inappropriate or suspicious, please report this activity to: www.iC3.gov or www.stopfraud.gov.